We’re harnessing Imperial’s innovation for global impact and entrepreneurship
We took home a big prize at the 2025 Times Higher Education Awards, as Imperial was named Outstanding Entrepreneurial University of the Year 2025 in recognition of our efforts in scaling science and taking West London to the world.
It’s a celebration of our thousands of students, researchers, entrepreneurs, partners, supporters and staff – everyone who works to make Imperial an extraordinary home for innovation and entrepreneurship
Modified insects could reduce disease and limit crop damage
A method to control harmful insects in the wild using genome engineering techniques to reduce fertility has attracted $19 million in equity and funding awards. Spinout Biocentis, based on research from Imperial’s Department of Life Sciences, will use the funds to begin field trials in first targets including a mosquito responsible for transmitting dengue, Zika, yellow fever and chikungunya.
6 new programmes will address ‘Grand Challenges’ in antimicrobial resistance, harnessing leading science and the latest technologies, including advanced AI. Key themes include supercharging discovery of new antibiotics for Gram-negative bacterial infections and accelerating drug discovery to combat fungal infections like aspergillus.
Live events economy could be boosted by increased safety
Reporti, a company founded by Imperial alumna Gracie Broom, has won the Venture Catalyst Challenge, Imperial’s flagship entrepreneurial competition. The company, which is developing a platform to increase live event safety, received the award after pitching at London’s Science Museum earlier this month.
Recycling the dye in discarded garments is tough enough, but providing the exact colour matching demanded by high-end fashion? That’s previously been impossible. But Imperial spinout Dye Recycle has managed it, and dyes produced by their innovative process featured at London Fashion Week earlier this year, as profiled by Vogue Italia.
Eliminating cold-chain storage requirements could boost vaccine coverage
Cold-chain storage – the need to keep vaccines cold from production to delivery – has hampered the rollout of life-saving treatments in tropical and remote regions. A nanoparticle technology developed at Imperial’s Future Vaccine Manufacturing Research hub is looking to change that, and is the subject of a collaboration with GSK.
‘GPT for health’ boosted by one million hours of AI supercomputer time
Nightingale AI, a project led by Imperial College London, aims to help scientists and medical specialists with applications like developing treatments, diagnosing patients and monitoring illness. Its ambitions have been boosted with the grant of a million hours of compute time on Isambard-AI, the UK’s most powerful AI supercomputer.
Robust wireless power transfer could change the way we approach space exploration
A company founded by Imperial scientists will use its expertise in lightweight systems that deliver high power levels over a significant air gap to explore new ways to transmit power in outer space, working with MDA Space, thanks to a grant from the UK Space Agency.
To explore how Imperial Enterprise could help your business benefit from Imperial’s world-leading expertise, technologies, resources and talented innovators, view our LinkedIn, website or drop us a line today.
